GPT-Rosalind (OpenAI) vs DeepSeek
Which one should you pick? Here's the full breakdown.
GPT-Rosalind (OpenAI)
OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)
DeepSeek
Near-frontier reasoning for pennies on the dollar -- the open-source LLM that made Silicon Valley nervous
| Category | GPT-Rosalind (OpenAI) | DeepSeek |
|---|---|---|
| Ease of Use | 3.0 | 7.5 |
| Output Quality | 9.0 | 8.0 |
| Value | 7.0 | 9.5 |
| Features | 8.0 | 7.0 |
| Overall | 6.8 | 8.0 |
Pricing Comparison
| Feature | GPT-Rosalind (OpenAI) | DeepSeek |
|---|---|---|
| Free Tier | No | Yes |
| Starting Price | Invite only | $0 |
Benchmark Head-to-Head
DeepSeek V3.2 benchmarks — GPT-Rosalind (OpenAI) has no published benchmarks
| Benchmark | Description | Score |
|---|---|---|
| MMLU | Knowledge across 57 subjects | 90.8% |
| MMLU-Pro | Harder multi-subject reasoning | 85% |
| GPQA Diamond | Graduate-level science questions | 79.9% |
| HumanEval | Python code generation | 91.5% |
| SWE-bench | Real GitHub issue fixing | 67.8% |
Which Should You Pick?
Pick GPT-Rosalind (OpenAI) if...
- ✓Higher output quality (9 vs 8)
- ✓More features (8 vs 7)
Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.
Visit GPT-Rosalind (OpenAI)Pick DeepSeek if...
- ✓Easier to use (7.5 vs 3)
- ✓Better value for money (9.5/10)
- ✓Has a free tier
Developers and teams who need strong reasoning and coding capabilities on a budget. If you're building AI features and can't justify GPT-4 API costs, DeepSeek is the obvious first stop.
Visit DeepSeekOur Verdict
DeepSeek is the clear winner here with 8.0/10 vs 6.8/10. GPT-Rosalind (OpenAI) isn't bad, but DeepSeek outperforms it across the board. Pick GPT-Rosalind (OpenAI) only if researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access.